FOXA1 and nasopharyngeal carcinoma: Concomitant alterations in BMI1 expression and H2AK119ub1 levels (a repressive chromatin marker catalyzed by BMI1 as the core enzymatic component of PRC1) were observed following FOXA1 knockdown and overexpression in NPC cells.